← Leaderboards
Ingrid A Binswanger
University Of Colorado Denver
$5,265,673
Attributed
$8,969,189
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,526,944 · 7
CDC$799,728 · 1
By mechanism
R01$6,132,280 · 2
UG1$1,357,483 · 1
R34$836,812 · 1
U01$799,728 · 1
R56$475,024 · 1
R21$420,750 · 1
Top collaborators
- Jason M Glanz16 shared
- Katharine Anthony Bradley4 shared
- Cynthia I Campbell4 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Spero M Manson$45,709,705
- Walter Perry Dickinson$20,394,243
- Amy Grotelueschen Huebschmann$3,251,318
- Jason Hoppe$3,887,640
- Kelsey R Hills-Dunlap$171,702
Others in their field
Top investigators on “Overdose”
- Sharon L. Walsh · University Of Kentucky$91,520,716
- Jeffrey H Samet · Boston University Medical Campus$88,233,622
- T John Winhusen · University Of Cincinnati$57,469,042
- Edward V Nunes · Columbia University Health Sciences$38,602,788
- Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai$32,706,021
- Rebecca D Jackson · Ohio State University$29,698,788
Research focus
OverdoseHealth SystemPharmaceutical PreparationsOverdose DeathOpioidUnited StatesPrescription OpioidMedicalCessation Of LifeSubstance Use DisorderLeadElectronic Health RecordCommunitiesPreventColoradoSafetyProviderChronicBaseOpioid OverdoseHospitalsResearch PersonnelPublic HealthNaloxone
Grant awards (28)
Health Systems Node of the NIDA Clinical Trials Network$821,439
UG1 · FY2025 · DA
Health Systems Node of the NIDA Clinical Trials Network (CTN Project: Secondary Papers)$289,776
UG1 · FY2025 · DA
Health Systems Node of the NIDA Clinical Trials Network (CTN Project: CTN-141 Hlth Ins Instability)$200,000
UG1 · FY2025 · DA
Health Systems Node of the NIDA Clinical Trials Network (CTN-0139)$46,268
UG1 · FY2025 · DA
Assessing the Safety and Effectiveness of Opioid Tapering in Large Health Systems$708,769
R01 · FY2022 · DA · contact PI
Assessing the Safety and Effectiveness of Opioid Tapering in Large Health Systems$541,951
R01 · FY2021 · DA · contact PI
Assessing the Safety and Effectiveness of Opioid Tapering in Large Health Systems$163,172
R01 · FY2021 · DA · contact PI
The Safety and Impact of Expanded Access to Naloxone in Health Systems$633,265
R01 · FY2020 · DA · contact PI
Assessing the Safety and Effectiveness of Opioid Tapering in Large Health Systems$549,946
R01 · FY2020 · DA · contact PI
The Safety and Impact of Expanded Access to Naloxone in Health Systems$615,456
R01 · FY2019 · DA · contact PI
Assessing the Safety and Effectiveness of Opioid Tapering in Large Health Systems$588,255
R01 · FY2019 · DA · contact PI
The Safety and Impact of Expanded Access to Naloxone in Health Systems$161,892
R01 · FY2019 · DA · contact PI
The Safety and Impact of Expanded Access to Naloxone in Health Systems$122,232
R01 · FY2019 · DA · contact PI
The Safety and Impact of Expanded Access to Naloxone in Health Systems$640,139
R01 · FY2018 · DA · contact PI
Assessing the Unintended Consequences of Restrictive Opioid Pain Reliever Policies$400,000
U01 · FY2018 · CE · contact PI
Diversity Supplement to R01DA042059$122,232
R01 · FY2018 · DA · contact PI
The Safety and Impact of Expanded Access to Naloxone in Health Systems$652,539
R01 · FY2017 · DA · contact PI
Applying Big Data Analytics to Study the Impact of Opioid Prescribing Policy Changes on Prescribing Behavior and Overdose Outcomes$475,024
R56 · FY2017 · DA
Assessing the Unintended Consequences of Restrictive Opioid Pain Reliever Policies$399,728
U01 · FY2017 · CE · contact PI
The Safety and Impact of Expanded Access to Naloxone in Health Systems$632,432
R01 · FY2016 · DA · contact PI
Overdose Risk Assessment, Counseling and Naloxone Prescription in Health Care$219,556
R34 · FY2015 · DA · contact PI
Overdose Risk Assessment, Counseling and Naloxone Prescription in Health Care$222,729
R34 · FY2014 · DA · contact PI
Overdose Risk Assessment, Counseling and Naloxone Prescription in Health Care$139,516
R34 · FY2014 · DA · contact PI
Overdose Risk Assessment, Counseling and Naloxone Prescription in Health Care$255,011
R34 · FY2013 · DA · contact PI
Drug-Related Risk for Death After Release from Prison$153,000
R21 · FY2012 · DA · contact PI
Drug-Related Risk for Death After Release from Prison$267,750
R21 · FY2011 · DA · contact PI
HIV Risk Behavior in Drug-Involved Former Inmates$151,470
R03 · FY2011 · DA · contact PI
HIV Risk Behavior in Drug-Involved Former Inmates$153,125
R03 · FY2010 · DA · contact PI